Sufentanil Citrate (SUFENTANIL CITRATE (Sufentanil Citrate) Injection) 50 ug/mL

Sufentanil citrate injection is a potent opioid analgesic used for pain management in clinical settings. This 50 ug/mL formulation provides rapid relief for moderate to severe pain. Commonly administered in hospitals and surgical environments. Short-acting with high potency for precise dosing.

Strength

50 ug/mL

Manufacturer / TM Owner

Hospira, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sufentanil citrate is primarily used to manage acute pain in medical and surgical settings. It is often employed for anesthesia induction, maintenance during procedures, or postoperative pain relief. The medication is suitable for patients requiring strong, short-acting pain control. Healthcare professionals may use it for both adult and pediatric cases depending on clinical need.

Side Effects

Sufentanil citrate produces rapid pain relief shortly after administration, typically within minutes. Patients may experience sedation and relaxation alongside pain reduction. The effects are short-lived, allowing for quick titration based on patient response. Some individuals report dizziness or lightheadedness during recovery.

Precautions & Warnings

This medication should only be administered by trained healthcare providers in a controlled environment. Patients must be closely monitored for respiratory depression and other opioid-related side effects. Dosage adjustments are necessary for elderly or debilitated patients. Always disclose full medical history, including respiratory conditions or substance use.

Avoid Interactions

Concurrent use with other central nervous system depressants, such as benzodiazepines or alcohol, may increase sedation and respiratory risks. CYP3A4 inhibitors can prolong sufentanil’s effects by slowing metabolism. Patients taking MAO inhibitors should avoid sufentanil due to potential severe interactions. Always review full medication list before administration.

Frequently Asked Questions

It is used for managing moderate to severe pain in clinical settings, including surgical anesthesia and postoperative care.

Pain relief typically begins within minutes of administration due to its rapid onset of action.

Use in pediatric patients is determined by healthcare providers based on individual medical needs and safety considerations.

Mixing should only occur under direct medical supervision to prevent adverse interactions or dosing errors.

Common effects include dizziness, sedation, and temporary respiratory changes during recovery.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.